The World Immunisation Week (WIW) campaign this year 2022 has been launched to remind us that immunisation provides an opportunity for everyone to enjoy a more fulfilling life. The WIW is organised in April every year by the World Health Organisation (WHO) to highlight the collective action needed and to promote the use of vaccines to protect people of all ages against disease. This year the featured theme is #LongLifeforall and the PROMISE consortium joins this effort by paving the way to Respiratory syncytial virus (RSV) disease prevention and immunisation.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 101034339. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences.